EUVIMEDEUVIMED entdecken
Mixed-Methods-Studie

A Mixed-Methods Approach to Understanding Barriers and Facilitators to Proactive Autoantibody Testing for Early-Stage Type 1 Diabetes Among U.S. Family Physicians and Pediatricians

Jay H. Shubrook, Shpetim Karandrea, Lauren Welch, Tom Bregartner, Marissa Mays-Verman, Daniel Rojas, Eric Du, Richard J. Spiegel

Diabetes, Obesity, and CardioMetabolic CARE · 16.11.2026

DOI: 10.2337/doc26-0089 ↗

Kurz gefasst

Mixed-Methods-Studie in der Zeitschrift Diabetes, Obesity, and CardioMetabolic CARE, online erschienen am 16.11.2026. Verfasst von Jay H. Shubrook und 7 weiteren Autor:innen. Gefördert von: Sanofi.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE Early detection of type 1 diabetes through islet autoantibody (IAb) testing can improve disease trajectory and reduce complications. To optimize efforts to improve IAb screening, research is needed to better understand the facilitators and barriers to screening among U.S. physicians. RESEARCH DESIGN AND METHODS This mixed-methods study, which used the Theoretical Domains Framework from implementation science, was designed to identify key barriers and facilitators to IAb screening among U.S. physicians, prioritize those barriers and facilitators to identify where efforts to support practice change are most needed, and link those barriers and facilitators to behavioral change techniques (BCTs) to improve screening behaviors. The qualitative phase included interviews with family medicine physicians (n = 15) and pediatricians (n = 15). The quantitative phase used maximum difference scaling to rank physicians’ (n = 200) facilitators and barriers and regression modeling to assess whether priority barriers and facilitators predict screening behavior. RESULTS Twelve key barriers and facilitators emerged (e.g., lacking awareness of presymptomatic IAb testing, believing presymptomatic testing would have negative impacts on patients). BCTs associated with these included feedback, persuasive communication, and self-monitoring. Family physicians prioritized knowledge gaps as a key barrier (e.g., not understanding the application of IAb testing in detecting presymptomatic type 1 diabetes), whereas pediatricians prioritized motivational barriers (e.g., IAb testing not being a high clinical priority). CONCLUSIONS Findings reveal new insights into U.S. physician screening behaviors for presymptomatic type 1 diabetes. These results could inform the development and implementation of targeted, actionable communication strategies and other interventions to support routine IAb testing.

Förderung

  • Sanofi

Zitieren

APA

Shubrook, J. H., Karandrea, S., Welch, L., Bregartner, T., Mays-Verman, M., Rojas, D., Du, E., & Spiegel, R. J. (2026). A Mixed-Methods Approach to Understanding Barriers and Facilitators to Proactive Autoantibody Testing for Early-Stage Type 1 Diabetes Among U.S. Family Physicians and Pediatricians. Diabetes, Obesity, and CardioMetabolic CARE. https://doi.org/10.2337/doc26-0089

Vancouver

Shubrook JH, Karandrea S, Welch L, Bregartner T, Mays-Verman M, Rojas D, et al. A Mixed-Methods Approach to Understanding Barriers and Facilitators to Proactive Autoantibody Testing for Early-Stage Type 1 Diabetes Among U.S. Family Physicians and Pediatricians. Diabetes, Obesity, and CardioMetabolic CARE. 2026. doi:10.2337/doc26-0089

BibTeX
@article{Shubrook2026,
  author = {Shubrook, Jay H. and Karandrea, Shpetim and Welch, Lauren and Bregartner, Tom and Mays-Verman, Marissa and Rojas, Daniel and Du, Eric and Spiegel, Richard J.},
  title = {A Mixed-Methods Approach to Understanding Barriers and Facilitators to Proactive Autoantibody Testing for Early-Stage Type 1 Diabetes Among U.S. Family Physicians and Pediatricians},
  journal = {Diabetes, Obesity, and CardioMetabolic CARE},
  year = {2026},
  doi = {10.2337/doc26-0089}
}
Kostenlos starten →